NASDAQ:IRIX IRIDEX (IRIX) Stock Price, News & Analysis $2.00 -0.01 (-0.50%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$1.91▼$2.0050-Day Range$1.76▼$2.1552-Week Range$1.63▼$3.65Volume10,492 shsAverage Volume30,751 shsMarket Capitalization$32.51 millionP/E RatioN/ADividend YieldN/APrice Target$2.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get IRIDEX alerts: Email Address IRIDEX MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/DownsideN/AShort InterestBearish2.66% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.52) to ($0.27) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.03 out of 5 starsComputer And Technology Sector592nd out of 594 stocksElectromedical Equipment Industry22nd out of 22 stocks 1.0 Analyst's Opinion Consensus RatingIRIDEX has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageIRIDEX has received no research coverage in the past 90 days.Read more about IRIDEX's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted2.66% of the float of IRIDEX has been sold short.Short Interest Ratio / Days to CoverIRIDEX has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.Change versus previous monthShort interest in IRIDEX has recently decreased by 2.07%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldIRIDEX does not currently pay a dividend.Dividend GrowthIRIDEX does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for IRIX. Previous Next 0.6 News and Social Media Coverage News Coverage This WeekMarketBeat has tracked 1 news article for IRIDEX this week, compared to 0 articles on an average week.Search Interest1 people have searched for IRIX on MarketBeat in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, IRIDEX insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.20% of the stock of IRIDEX is held by insiders.Percentage Held by InstitutionsOnly 20.10% of the stock of IRIDEX is held by institutions.Read more about IRIDEX's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for IRIDEX are expected to grow in the coming year, from ($0.52) to ($0.27) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of IRIDEX is -2.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of IRIDEX is -2.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioIRIDEX has a P/B Ratio of 7.69. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about IRIDEX's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About IRIDEX Stock (NASDAQ:IRIX)IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.Read More IRIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IRIX Stock News HeadlinesSeptember 6 at 2:11 AM | americanbankingnews.comIRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.comAugust 30, 2024 | americanbankingnews.comIRIDEX (NASDAQ:IRIX) Receives New Coverage from Analysts at StockNews.comSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 28, 2024 | americanbankingnews.comIRIDEX (NASDAQ:IRIX) Research Coverage Started at StockNews.comAugust 26, 2024 | seekingalpha.comIridex Frustrates, But Expect A Transaction By Year-EndAugust 16, 2024 | ca.finance.yahoo.comDDD Jan 2025 10.000 callAugust 10, 2024 | seekingalpha.comIRIDEX Corporation (IRIX) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | markets.businessinsider.comIridex Reports Second Quarter 2024 Financial ResultsSeptember 7, 2024 | Porter & Company (Ad)Trump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. Hopelessness abounds. And looking in, the future here looks bleak for these forgotten souls. But in a strange twist of fate, something miraculous is taking place…August 8, 2024 | uk.investing.comIridex secures $3.5 million in private placement financingAugust 5, 2024 | finance.yahoo.comIridex Announces Convertible Note FinancingMay 22, 2024 | finance.yahoo.comIRIDEX Corporation (IRIX)May 19, 2024 | msn.comIRIDEX Corporation (NASDAQ:IRIX) Q1 2024 Earnings Call TranscriptMay 19, 2024 | uk.investing.comEarnings call: IRIDEX reports Q1 2024 revenue decline, ongoing strategic reviewMay 15, 2024 | finance.yahoo.comIRIDEX Corp (IRIX) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges with ...May 14, 2024 | investorplace.comIRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | globenewswire.comIridex Reports First Quarter 2024 Financial ResultsMay 14, 2024 | finance.yahoo.comEven after rising 11% this past week, IRIDEX (NASDAQ:IRIX) shareholders are still down 59% over the past three yearsSee More Headlines Receive IRIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/07/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorComputer and Technology Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:IRIX CUSIPN/A CIK1006045 Webwww.iridex.com Phone(650) 940-4700Fax650-940-4710Employees120Year Founded1989Price Target and Rating Average Stock Price Target$2.00 High Stock Price Target$2.00 Low Stock Price Target$2.00 Potential Upside/Downside0.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.67) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,570,000.00 Net Margins-21.84% Pretax Margin-21.59% Return on Equity-134.37% Return on Assets-32.23% Debt Debt-to-Equity RatioN/A Current Ratio1.55 Quick Ratio0.86 Sales & Book Value Annual Sales$49.70 million Price / Sales0.65 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book7.69Miscellaneous Outstanding Shares16,253,000Free Float15,245,000Market Cap$32.51 million OptionableOptionable Beta0.83 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. David I. Bruce (Age 65)President, CEO & Director Comp: $397.19kMr. Fuad Ahmad (Age 54)Interim Chief Financial Officer Comp: $356.83kMr. Patrick Mercer (Age 52)Chief Operating Officer Comp: $365.85kMs. Leigh SalvoHead of Investor RelationsKey CompetitorsRockwell MedicalNASDAQ:RMTIEdap TmsNASDAQ:EDAPBrainsWayNASDAQ:BWAYKORU Medical SystemsNASDAQ:KRMDFONARNASDAQ:FONRView All CompetitorsInstitutional OwnershipDimensional Fund Advisors LPSold 23,889 shares on 8/9/2024Ownership: 0.150%View All Institutional Transactions IRIX Stock Analysis - Frequently Asked Questions How have IRIX shares performed this year? IRIDEX's stock was trading at $2.81 at the start of the year. Since then, IRIX shares have decreased by 28.8% and is now trading at $2.00. View the best growth stocks for 2024 here. How were IRIDEX's earnings last quarter? IRIDEX Co. (NASDAQ:IRIX) announced its quarterly earnings data on Thursday, August, 8th. The medical equipment provider reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.04. The medical equipment provider had revenue of $12.63 million for the quarter, compared to analyst estimates of $12.80 million. IRIDEX had a negative net margin of 21.84% and a negative trailing twelve-month return on equity of 134.37%. What is Theodore A. Boutacoff's approval rating as IRIDEX's CEO? 7 employees have rated IRIDEX Chief Executive Officer Theodore A. Boutacoff on Glassdoor.com. Theodore A. Boutacoff has an approval rating of 64% among the company's employees. Who are IRIDEX's major shareholders? IRIDEX's top institutional investors include Dimensional Fund Advisors LP (0.15%). Insiders that own company stock include Nandini Devi and Robert Earle Grove. View institutional ownership trends. How do I buy shares of IRIDEX? Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of IRIDEX own? Based on aggregate information from My MarketBeat watchlists, some other companies that IRIDEX investors own include NVIDIA (NVDA), Trevena (TRVN), CTI BioPharma (CTIC), Agile Therapeutics (AGRX), Genocea Biosciences (GNCA) and Idera Pharmaceuticals (IDRA). This page (NASDAQ:IRIX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
